Lin Ping
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 3
- Diabetes Management and Research 2
- Co-authors
- Matthew C. Riddle (4 shared papers)Jeffrey L. Probstfield (2 shared papers)Francesca C. Lawson (2 shared papers)John J.V. McMurray (2 shared papers)Scott David Solomon (2 shared papers)Hertzel C. Gerstein (2 shared papers)Marc Alan Pfeffer (2 shared papers)Rafael Ugarriza Díaz (2 shared papers)
- Journals
- Pediatric Diabetes (2 papers)Diabetes Care (2 papers)Diabetes Technology & Therapeutics (1 paper)American Heart Journal (1 paper)Chinese Journal of Natural Medicines (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Lin Ping
10 papers receiving 2.5k citations
Lin Ping's Hit Papers
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 2.2k
- Pharmacology 329
- Surgery 570
- Cardiology and Cardiovascular Medicine 259
- Molecular Biology 656
Countries citing papers authored by Lin Ping
This map shows the geographic impact of Lin Ping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Ping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Ping more than expected).
Fields of papers citing papers by Lin Ping
This network shows the impact of papers produced by Lin Ping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Ping. The network helps show where Lin Ping may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Ping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Hit paper breakdown → | 2015 | 1926 |
| 2 | 2013 | 261 | |
| 3 | 2013 | 231 | |
| 4 | 2015 | 87 | |
| 5 | 2013 | 31 | |
| 6 | 2017 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2014 | 9 | |
| 9 | Preliminary Studies on Anticoagulant Function of Dendrobium chrysanthum | 2005 | 4 |
| 10 | 2018 | 1 |
About Lin Ping
Lin Ping is a scholar working on Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology, Inorganic Chemistry, Nutrition and Dietetics and Pharmacology, having authored 10 papers that have together received 2.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Diabetes Management and Research (2 papers), Synthesis and biological activity (1 paper), Biological and pharmacological studies of plants (1 paper), Bioactive natural compounds (1 paper), Metal complexes synthesis and properties (1 paper), Sodium Intake and Health (1 paper) and Crystal structures of chemical compounds (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Pharmacology (329 citations), Surgery (570 citations), Cardiology and Cardiovascular Medicine (259 citations) and Molecular Biology (656 citations). Lin Ping has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Matthew C. Riddle, Jeffrey L. Probstfield, Francesca C. Lawson, John J.V. McMurray, Scott David Solomon, Hertzel C. Gerstein, Marc Alan Pfeffer, Rafael Ugarriza Díaz, Lars Køber and Aldo Pietro Maggioni. Their work appears in journals such as Pediatric Diabetes, Diabetes Care, Diabetes Technology & Therapeutics, American Heart Journal and Chinese Journal of Natural Medicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.